首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1629591

全EXOME定序市場：按產品類型、按技術、按應用、按適應症、按最終用戶、按地區

Whole Exome Sequencing Market, By Product Type, By Technology, By Application, By Indication, By End User, By Geography

出版日期: 2024年12月04日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球全EXOME定序市場規模估計為 18 億美元，預計 2031 年將達到 47.2 億美元，2024 年至 2031 年的複合年成長率為 14.8%。

報告範圍		報告詳細資訊
基準年	2023	2024 年的市場規模	18億美元
效能資料	2019 年至 2023 年	預測期	2024 年至 2031 年
預測期間 2024 年至 2031 年複合年成長率：	14.80％	2031 年價值預測	47.2億美元

圖。

全EXOME定序是一種強大的技術，可以分析基因的整個蛋白質轉錄區以檢測致病的遺傳變異。近年來，它徹底改變了臨床診斷和基因研究。由於癌症研究應用的不斷增加、個人化醫療的需求不斷成長以及全基因組定序相對於傳統定序技術的日益普及，全EXOME序市場預計將見證顯著成長。

市場動態：

全球全EXOME定序市場受到慢性病盛行率上升、研究活動資金增加、全EXOME定序在藥物發現的應用不斷擴大以及精準醫療的推動。然而，預算限制、對熟練人力的需求以及缺乏適當的報銷政策限制了市場的成長。新興經濟體、持續的技術進步和不斷加強的產學研合作為市場參與者提供了機會。

本研究的主要特點

本報告對全球EXOME定序市場進行了詳細分析，並提供了預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2023 年。

它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球全EXOME定序市場的主要企業根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行分析。

研究中介紹的主要企業包括 Illumina, Inc.、Thermo Fisher Scientific Inc.、BGI Genomics、Agilent Technologies, Inc.、Roche Diagnostics、QIAGEN NV、Pacific Biosciences of California, Inc.、Oxford Nanopore Technologies plc、Eurofins Scients Sci。 Ltd.、Laboratory Corporation of America Holdings 和 Novogene Corporation。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興車型、市場擴張和行銷策略做出明智的決策。

全球全外EXOME定序市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過分析全球全EXOME定序市場所使用的各種策略矩陣來促進他們的決策。

Illumina, Inc.
Thermo Fisher Scientific Inc.
BGI Genomics
Agilent Technologies, Inc.
Roche Diagnostics
QIAGEN NV
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies plc
Eurofins Scientific SE
Genomatix GmbH
Myriad Genetics, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Novogene Corporation

第 11 章分析師建議

命運之輪
分析師觀點
一致的機會圖

第 12 章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI7571

The global whole exome sequencing market is estimated to be valued at USD 1.80 Bn in 2024 and is expected to reach USD 4.72 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 1.80 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	14.80%	2031 Value Projection:	US$ 4.72 Bn

Figure. Whole Exome Sequencing Market Share (%), By Region 2024

Whole exome sequencing is a powerful technology that allows analyzing the entire protein-coding region of genes in order to detect genetic variations responsible for diseases. It has revolutionized clinical diagnosis and genetic research in recent years. Whole exome sequencing market is expected to experience significant growth due to rising applications in cancer research, increasing demand for personalized medicine, and growing popularity of whole genome sequencing over traditional sequencing techniques.

Market Dynamics:

The global whole exome sequencing market is driven by rising incidence of chronic diseases, increased funding for research activities, growing applicability of whole exome sequencing in drug discovery, and precision medicine. However, budget constraints, requirement of skilled personnel and non-availability of adequate reimbursement policies limit the market growth. The market provides opportunities for players due to emerging economies, continuous technological advancements, and increasing collaborations between industry and academia.

Key Features of the Study:

This report provides in-depth analysis of the global whole exome sequencing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global whole exome sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Inc., Thermo Fisher Scientific Inc., BGI Genomics, Agilent Technologies, Inc., Roche Diagnostics, QIAGEN N.V., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, Eurofins Scientific SE, Genomatix GmbH, Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, and Novogene Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global whole exome sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global whole exome sequencing market

Market Segmentation

By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Instruments
- Consumables
- Services
By Technology Insights (Revenue, USD Bn, 2019 - 2031)
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Other Technologies
By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Drug Discovery & Development
- Clinical Diagnostics
- Research
By Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Cancer
- Rare/Inherited Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Diagnostics Laboratories
- Academic and Research Institutes
- Biopharmaceutical Companies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics
- Agilent Technologies, Inc.
- Roche Diagnostics
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies plc
- Eurofins Scientific SE
- Genomatix GmbH
- Myriad Genetics, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Novogene Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Whole Exome Sequencing Market, By Product Type
- Global Whole Exome Sequencing Market, By Technology
- Global Whole Exome Sequencing Market, By Application
- Global Whole Exome Sequencing Market, By Indication
- Global Whole Exome Sequencing Market, By End User
- Global Whole Exome Sequencing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Whole Exome Sequencing Market, By Product Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Whole Exome Sequencing Market, By Technology, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Sequencing by Synthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ion Semiconductor Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Whole Exome Sequencing Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Whole Exome Sequencing Market, By Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rare/Inherited Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Whole Exome Sequencing Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostics Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Whole Exome Sequencing Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Technology, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
Roche Diagnostics
QIAGEN N.V.
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies plc
Eurofins Scientific SE
Genomatix GmbH
Myriad Genetics, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Novogene Corporation